Read More Pharma Industry News Lilly bets $7.8bn on orexin science with Centessa acquisition as neuroscience race intensifies Eli Lilly agrees to acquire Centessa Pharmaceuticals for $6.3B, gaining orexin sleep drug cleminorexton. Read the full strategic analysis. byVenkateshApril 2, 2026